Outpatient sedation is a common requirement across multiple healthcare specialties. However, managing sedation for patients who are currently taking buprenorphine—a partial opioid agonist often used to treat opioid use disorder (OUD) or chronic pain—presents unique challenges and risks that every provider should recognize before proceeding.
Understanding Buprenorphine’s Pharmacology
Buprenorphine acts as a partial agonist at the mu-opioid receptor, binding strongly and displacing other opioids. This high receptor affinity limits the effectiveness of full opioid agonists commonly used during sedation and analgesia. In practice, this means that "standard" doses of opioids like fentanyl may not provide sufficient pain relief or sedation when combined with buprenorphine.
Why It Matters for Outpatient Sedation
Patients on buprenorphine can be difficult to sedate using opioid-based regimens. Attempts to use additional opioids may result in inadequate analgesia due to receptor saturation, while abruptly stopping buprenorphine before a procedure risks precipitated withdrawal and even relapse in those using it for OUD.
Principles for Safe, Effective Sedation
1. Do Not Discontinue Buprenorphine Without a Plan:
Abrupt cessation is usually discouraged, especially in outpatient or elective settings. Any decision to adjust the dose or schedule should be made in conjunction with the patient's buprenorphine prescriber, who can help coordinate continuity of care, minimize withdrawal, and support recovery.
2. Use Multimodal Analgesia and Sedation:
Lean on non-opioid agents wherever possible:
• NSAIDs, acetaminophen, gabapentinoids, or ketamine can enhance analgesia.
• Regional or local anesthetic techniques (nerve blocks, infiltration) effectively supplement systemic agents.
• Consider alpha-2 agonists (like clonidine or dexmedetomidine), magnesium, or IV lidocaine.
• Psychosocial approaches such as distraction, relaxation apps, and peer support further bolster the comfort of the patient
3. Adjust Your Expectations for Opioid Sedation:
Be aware that even high doses of traditional opioids may offer limited efficacy due to buprenorphine’s receptor blockade. Carefully document any opioid use, consider time-limited prescriptions, and taper short-acting opioids before discharge to prevent dual therapy complications and overdose.
The Need for Teamwork
Engage the patient's buprenorphine prescriber early:
• Plan for pain management before, during, and after the procedure.
• Clarify post-operative medication plans, ensuring the patient can seamlessly transition back to their maintenance regimen.
• Coordinate follow-up support, especially if there have been adjustments during peri-procedural.
Additional Risks
Buprenorphine can cause side effects such as constipation, sweating, and sleep disturbances. Sedation regimens should be adjusted for these factors. Always assess the risk of overdose if combining other CNS depressants or opioids, and educate patients about these risks.
Take-Home Points
• Buprenorphine’s strong receptor affinity minimizes the effect of additional opioids.
• Do not stop or change buprenorphine therapy without consulting the prescriber.
• Multimodal, opioid-sparing approaches are both safe and effective for outpatient sedation.
• Coordinate closely with addiction medicine, pain management, and pharmacy.
• Educate patients about perioperative risks and follow-up requirements.
By following these principles and using a team-based approach, non-anesthesiologists can provide safe outpatient sedation for patients who are maintained on buprenorphine, optimizing comfort while reducing the risk of withdrawal, relapse, and poorly controlled pain.cha
Sources:
1. Perioperative Management of a Patient Taking Suboxone® at the ... (PMC)pmc.ncbi.nlm.nih
2. Perioperative pain management guidance for patients on chronic buprenorphine (VA)va
3. Buprenorphine And The Anesthesia Considerations - DUNEdune.une
4. Acute Pain and Perioperative Management in Opioid Use Disorder (CHA)cha
5. Brigham and Women's Faulkner Hospital Outpatient Buprenorphine ...brighamandwomens
6. Buprenorphine Treatment for Opioid Use Disorder: An Overview - PMCpmc.ncbi.nlm.nih
7. Continuing Buprenorphine or Naltrexone-Containing Drugs in Peri-Operative Patients (OHSU)